The latest medical research on Neuroendocrine Tumors

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about neuroendocrine tumors gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access

Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.

Neuroendocrine Tumors

Cushing's disease is a rare, but devastating and difficult to manage condition. The somatostatin analogue pasireotide is the only pituitary targeti...

Association of DNA methylation with steroidogenic enzymes in Cushing's adenoma.

Neuroendocrine Tumors

DNA methylation and demethylation regulate the transcription of genes. DNA methylation-associated gene expression of adrenal steroidogenic enzymes ...

The effects of exercise and diet on sex steroids in breast cancer survivors.

Neuroendocrine Tumors

Insufficient physical activity and obesity are associated with an increased risk of cancer recurrence and death in breast cancer survivors. Sex ste...

Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer.

Neuroendocrine Tumors

Endocrine therapies are the main treatment strategies for the clinical management of hormone-dependent breast cancer. Despite prolonged time to rec...

Is there a role for diagnostic scans in the management of intermediate-risk thyroid cancer?

Neuroendocrine Tumors

Radioiodine (RAI) is selectively recommended for intermediate-risk differentiated thyroid carcinomas (DTC). The information gleaned from pretherapy...

Clinicopathological features and outcomes of thyroid nodules with EIF1AX mutations.

Neuroendocrine Tumors

EIF1AX gene mutations are reported in both benign and malignant thyroid tumors, with unclear outcomes when detected preoperatively. The aim of this...

MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells.

Neuroendocrine Tumors

Menin, encoded by the MEN1 gene, has been identified as a critical factor regulating ESR1 transcription, playing an oncogenic role in ER+ breast ca...

Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer.

Neuroendocrine Tumors

Differential diagnosis of thyroid cancer and benign nodules is still one of the most challenging issues in the field of endocrinology. To overcome ...

Metastatic medullary thyroid carcinoma: a new way forward.

Neuroendocrine Tumors

Medullary thyroid carcinoma (MTC) is a rare malignancy comprising 1-2% of all thyroid cancers in the United States. Approximately 20% of cases are ...

Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma.

Neuroendocrine Tumors

Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis and challenging management. The present study aimed to investigate expressi...

Exploring stem cell biology in pituitary tumors and derived organoids.

Neuroendocrine Tumors

Pituitary tumorigenesis is highly prevalent and causes major endocrine disorders. Hardly anything is known on the behavior of the local stem cells ...

Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review.

Neuroendocrine Tumors

Once temozolomide has failed, there is no recommended treatment option for pituitary carcinomas and aggressive pituitary tumors. Immune-checkpoint ...